1. Azin H, Ashjazadeh N. Cerebral venous sinus thrombosis--clinical features, predisposing and prognostic factors. Acta Neurol Taiwan. 17:82–87. 2008.
2. Boncoraglio G, Carriero MR, Chiapparini L, Ciceri E, Ciusani E, Erbetta A, et al. Hyperhomocysteinemia and other thrombophilic risk factors in 26 patients with cerebral venous thrombosis. Eur J Neurol. 11:405–409. 2004.
3. Boukobza M, Crassard I, Bousser MG, Chabriat H. Labbé vein thrombosis. Neuroradiology. 62:935–945. 2020.
Article
4. Ekseth K, Boström S, Vegfors M. Reversibility of severe sagittal sinus thrombosis with open surgical thrombectomy combined with local infusion of tissue plasminogen activator: technical case report. Neurosurgery. 43:960–965. 1998.
Article
5. Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - endorsed by the European Academy of Neurology. Eur J Neurol. 2:1203–1213. 2017.
Article
6. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 35:664–670. 2004.
Article
7. Furie KL, Cushman M, Elkind MSV, Lyden PD, Saposnik G; American Heart Association/American Stroke Association Stroke Council Leadership. Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia. Stroke. 52:2478–2482. 2021.
Article
8. Gazioglu S, Eyuboglu I, Yildirim A, Aydin CO, Alioglu Z. Cerebral venous sinus thrombosis: clinical features, long-term outcome and recanalization. J Clin Neurosci. 45:248–251. 2017.
Article
9. Guenther G, Arauz A. Cerebral venous thrombosis: a diagnostic and treatment update. Neurologia. 26:488–498. 2011.
Article
10. Khealani BA, Wasay M, Saadah M, Sultana E, Mustafa S, Khan FS, et al. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East. Stroke. 39:2707–2711. 2008.
11. Kourtopoulos H, Christie M, Rath B. Open thrombectomy combined with thrombolysis in massive intracranial sinus thrombosis. Acta Neurochir (Wien). 128:171–173. 1994.
Article
12. Lechanoine F, Janot K, Herbreteau D, Maldonado IL, Velut S. Surgical thrombectomy combined with bilateral decompressive craniectomy in a life-threatening case of coma from cerebral venous sinus thrombosis: case report and literature review. World Neurosurg. 120:485–489. 2018.
Article
13. Lee DJ, Ahmadpour A, Binyamin T, Dahlin BC, Shahlaie K, Waldau B. Management and outcome of spontaneous cerebral venous sinus thrombosis in a 5-year consecutive single-institution cohort. J Neurointerv Surg. 9:34–38. 2017.
Article
14. Lee DJ, Latchaw RE, Dahlin BC, Dong PR, Verro P, Muizelaar JP, et al. Antegrade rheolytic thrombectomy and thrombolysis for superior sagittal sinus thrombosis using burr hole access. BMJ Case Rep. 2014; bcr2013011087. 2014.
Article
15. Persson L, Lilja A. Extensive dural sinus thrombosis treated by surgical removal and local streptokinase infusion. Neurosurgery. 26:117–121. 1990.
Article
16. Pongmoragot J, Saposnik G. Intracerebral hemorrhage from cerebral venous thrombosis. Curr Atheroscler Rep. 14:382–389. 2012.
Article
17. Saposnik G, Barinagarrementeria F, Brown RD Jr, Bushnell CD, Cucchiara B, Cushman M, et al. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 42:1158–1192. 2011.
Article
18. See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. JAMA. 325:2448–2456. 2021.
Article
19. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 352:1791–1798. 2005.
Article
20. Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine. medRxiv. 2021; [Epub ahead of print].
Article
21. Westwick HJ, Obaid S, Bordeleau-Roy F, Truffer E, Weil AG. Surgical superior sagittal sinus thrombectomy in refractory thrombosis: a technical note. Pediatr Neurosurg. 54:212–217. 2019.
Article